
    
      The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to
      identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of
      these participants will be followed after serial dermal chelations and nutritional therapy.
    
  